SPRC$0.67635.05%-0.036
After Hours: 0.64-0.04 -5.37%
Scisparc Ltd (SPRC)
Date: 2026-10-30 16:00O: 0.6769H: 0.6843L: 0.6031C: 0.6763Vol: 343.4k
Scisparc Ltd stock is traded at $0.6763, with a volume of 343,410. It is down -5.05% in the last 24 hours and down -85.67% over the past month. SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
Previous Close:
$0.7123
Open:
$0.6769
24h Volume:
343,410
Relative Volume:
0.07
Market Cap:
$392.91K
Revenue:
$856.00K
Net Income/Loss:
-$12.56M
P/E Ratio:
-
EPS:
-$231.49
Net Cash Flow:
-$4.14M
1W Performance:
-37.95%
1M Performance:
-85.67%
6M Performance:
-92.29%
1Y Performance:
-97.69%
1-Day Range:
$0.6031$0.6843
1-Week Range:
$0.6031$1.78
52-Week Range:
$0.6031$30.87
Scisparc Ltd Stock (SPRC) Company Profile
Compare SPRC vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SPRC Scisparc Ltd | $0.6763 | $392.91K | $856.00K | -$12.56M | -$4.14M | -$231.49 |
 VRTX Vertex Pharmaceuticals Inc | $558.88 | $141.65B | $12.34B | $4.34B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $927.89 | $95.53B | $14.92B | $4.42B | $3.79B | $41.04 |
 MRNA Moderna Inc | $221.72 | $88.52B | $2.23B | -$3.19B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $892.87 | $56.15B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $370.33 | $41.89B | $5.76B | $514.49M | $1.10B | $4.48 |
Scisparc Ltd Stock (SPRC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Scisparc Ltd Stock (SPRC) Insider Trading
- Shrem ItschakJun 01 '26Director
- Transaction
- Sale
- Cost
- $10.00
- #Shares
- 462
- Value ($)
- 4,620
- #Shares Total
- 10,596
